These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21961199)

  • 21. Evaluation of efficacy of a new live Salmonella Typhimurium vaccine candidate in a murine model.
    Hur J; Kim MY; Lee JH
    Comp Immunol Microbiol Infect Dis; 2011 Mar; 34(2):171-7. PubMed ID: 21111480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and in vitro characterisation of aroA defective (aroAΔ) mutant Salmonella Infantis.
    Müştak İB; Yardımcı H
    Arch Microbiol; 2019 Nov; 201(9):1277-1284. PubMed ID: 31240343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of live attenuated Salmonella for oral vaccination.
    Chatfield S; Roberts M; Li J; Starns A; Dougan G
    Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of Salmonella-based vaccination strategies.
    Spreng S; Dietrich G; Weidinger G
    Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines.
    Husseiny MI; Hensel M
    Vaccine; 2005 Apr; 23(20):2580-90. PubMed ID: 15780440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed population approach for vaccination with live recombinant Salmonella strains.
    Yan ZX; Meyer TF
    J Biotechnol; 1996 Jan; 44(1-3):197-201. PubMed ID: 8717404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Explorative probes and biomarkers, chronic Salmonella infections and future vaccines.
    Michán C; Ramos JL; Daniels C
    Microb Biotechnol; 2012 Jan; 5(1):1-4. PubMed ID: 22103324
    [No Abstract]   [Full Text] [Related]  

  • 28.
    Clark-Curtiss JE; Curtiss R
    J Immunol; 2018 Jan; 200(1):39-48. PubMed ID: 29255088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.
    Kotton CN; Lankowski AJ; Scott N; Sisul D; Chen LM; Raschke K; Borders G; Boaz M; Spentzou A; Galán JE; Hohmann EL
    Vaccine; 2006 Sep; 24(37-39):6216-24. PubMed ID: 16824652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stable recombinant avirulent Salmonella vaccine strains.
    Curtiss R; Kelly SM; Gulig PA; Nakayama K
    Adv Exp Med Biol; 1989; 251():33-47. PubMed ID: 2692430
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccination and early protection against non-host-specific Salmonella serotypes in poultry: exploitation of innate immunity and microbial activity.
    Van Immerseel F; Methner U; Rychlik I; Nagy B; Velge P; Martin G; Foster N; Ducatelle R; Barrow PA
    Epidemiol Infect; 2005 Dec; 133(6):959-78. PubMed ID: 16274493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eye mucosa: an efficient vaccine delivery route for inducing protective immunity.
    Seo KY; Han SJ; Cha HR; Seo SU; Song JH; Chung SH; Kweon MN
    J Immunol; 2010 Sep; 185(6):3610-9. PubMed ID: 20709955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.
    Fensterle J; Bergmann B; Yone CL; Hotz C; Meyer SR; Spreng S; Goebel W; Rapp UR; Gentschev I
    Cancer Gene Ther; 2008 Feb; 15(2):85-93. PubMed ID: 18084243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salmonella type III-mediated heterologous antigen delivery: a versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors.
    Panthel K; Meinel KM; Sevil Domènech VE; Trülzsch K; Rüssmann H
    Int J Med Microbiol; 2008 Jan; 298(1-2):99-103. PubMed ID: 17719275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmonellae as oral vaccine carriers.
    Schödel F; Curtiss R
    Dev Biol Stand; 1995; 84():245-53. PubMed ID: 7796961
    [No Abstract]   [Full Text] [Related]  

  • 38. The specificity and importance of humoral antibody in the protection of mice against intraperitoneal challenge with complement-sensitive and complement-resistant Salmonella.
    Ornellas EP; Roantree RJ; Steward JP
    J Infect Dis; 1970 Feb; 121(2):113-23. PubMed ID: 4905646
    [No Abstract]   [Full Text] [Related]  

  • 39. Investigation of ansB and sspA derived promoters for multi- and single-copy antigen expression in attenuated Salmonella enterica var. typhimurium.
    Terry TD; Downes JE; Dowideit SJ; Mabbett AN; Jennings MP
    Vaccine; 2005 Aug; 23(36):4521-31. PubMed ID: 15982791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain?
    Raupach B; Kaufmann SH
    Microbes Infect; 2001; 3(14-15):1261-9. PubMed ID: 11755414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.